Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) | Apply Online

Opportunity Summary:

The Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) (Funding Opportunity Number PAR-09-160) is a National Institutes of Health (NIH), National Cancer Institute (NCI) funding opportunity intended to jump-start early-stage basic research that explains why cancer outcomes differ across populations. The program is sponsored jointly by NCI's Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB), and it focuses on basic, mechanistic science rather than clinical trials or service-delivery interventions. At its core, the FOA is looking for projects that dig into the underlying causes of cancer health disparities, with an emphasis on biological and genetic contributors and the mechanisms that connect those factors to differences in cancer incidence, progression, or outcomes.

The types of studies encouraged are exploratory by design, meaning the program is meant to support work that is still in the pilot, feasibility, or proof-of-concept stage. Examples of the kinds of activities this FOA explicitly supports include small pilot and feasibility studies, the development and testing of new methods or tools, secondary analyses of existing datasets, and other innovative mechanistic studies that can generate key preliminary findings. The goal is to fund ideas that are promising but not yet mature enough for a large, hypothesis-heavy R01, while still being rigorous and clearly anchored in basic cancer biology and disparity-focused questions.

A major secondary aim of the FOA is workforce and field development. NCI frames this opportunity as a way to help build and strengthen a nationwide community of scientists who have deep basic research expertise and who are committed to cancer health disparities research. In practice, that means the R21 mechanism is also positioned as a stepping-stone: it provides resources for investigators who may need an additional boost to collect preliminary data, refine approaches, or establish credibility in the area so they can later compete successfully for larger awards such as an R01. The announcement explicitly signals this "on-ramp" function, emphasizing that the funded work should help investigators advance toward sustained, independent research programs in basic disparities science.

This FOA uses the NIH Exploratory/Developmental Research Grant (R21) mechanism. It is described as running in parallel with a companion announcement of identical scientific scope, PAR-09-161, which uses a Cooperative Agreement (U01) mechanism. In simple terms, PAR-09-160 is the standard grant version (R21), while the companion U01 would typically imply a more coordinated arrangement with NIH involvement and possibly more structured collaboration expectations. Applicants are expected to choose the mechanism that best fits their project structure and the level of programmatic coordination implied by the mechanism.

Funding levels are capped in a way that matches the exploratory nature of the award. The FOA allows up to $275,000 in direct costs over two years, with a stated annual cap not to exceed $200,000 in direct costs per year. As with most NIH opportunities, awards are contingent on the availability of funds, and the FOA does not promise a fixed number of awards. There is no cost sharing or matching requirement indicated for applicants, which lowers administrative barriers and makes the opportunity more accessible to institutions that might not be able to contribute additional funds.

Eligibility is broad and includes many types of domestic organizations. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations with or without 501(c)(3) status (with the noted caveat that some nonprofit categories exclude institutions of higher education), state governments, and other eligible entities as clarified in the FOA text. The eligibility section also highlights institutions that are often central to cancer disparities research capacity-building, including Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and eligible federal agencies. This breadth aligns with the program's stated intention to help expand and diversify the national research community working on the biological and genetic bases of cancer disparities.

Administratively, this announcement was originally posted on April 16, 2009, and later archived after its final due dates in 2011 (with the current closing date listed as November 28, 2011, and an archive date of December 29, 2011). The CFDA numbers associated with the opportunity reflect its placement within NCI's research portfolio areas, including Cancer Cause and Prevention Research (93.393), Cancer Biology Research (93.396), and Cancer Control (93.399). The primary public link to the full FOA is provided through the NIH grants guide at http://grants.nih.gov/grants/guide/pa-files/PAR-09-160.html, and NIH listed the Office of Extramural Research (OER) webmaster contacts for technical access issues.

Taken together, PAR-09-160 is best understood as a targeted R21 program designed to produce early mechanistic insights and foundational data about biological and genetic drivers of cancer health disparities, while also strengthening the pipeline of researchers equipped to pursue larger, longer-term basic science programs in this area. It is aimed at researchers with innovative ideas that can be tested in a two-year exploratory window and translated into a stronger platform for future R01-level applications focused on the fundamental mechanisms behind unequal cancer burden.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Basic Cancer Research in Cancer Health Disparities (U01)

Previous opportunity: Improving the Capacity of Panel Physicians Performing Overseas Medical Assessments of U.S. Bound Immigrants and Refugees

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 09 160

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 09 160) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 09 160", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.